Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DALFAMPRIDINE Cause Product substitution issue? 182 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 182 reports of Product substitution issue have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 0.3% of all adverse event reports for DALFAMPRIDINE.

182
Reports of Product substitution issue with DALFAMPRIDINE
0.3%
of all DALFAMPRIDINE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product substitution issue From DALFAMPRIDINE?

Of the 182 reports, 4 (2.2%) required hospitalization.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DALFAMPRIDINE. However, 182 reports have been filed with the FAERS database.

What Other Side Effects Does DALFAMPRIDINE Cause?

Gait disturbance (8,780) Drug ineffective (6,794) Fall (5,554) Therapy cessation (4,580) Fatigue (3,778) Balance disorder (3,753) Multiple sclerosis relapse (3,322) Condition aggravated (3,240) Dizziness (2,959) Urinary tract infection (2,757)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which DALFAMPRIDINE Alternatives Have Lower Product substitution issue Risk?

DALFAMPRIDINE vs DALTEPARIN DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL DALFAMPRIDINE vs DANAPAROID DALFAMPRIDINE vs DANAZOL DALFAMPRIDINE vs DANICOPAN

Related Pages

DALFAMPRIDINE Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue DALFAMPRIDINE Demographics